Related Experiment Video
Updated: Aug 14, 2026

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1
Woo Je Lee1, Mina Kim, Hye-Sun Park
1Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract:
AMP-activated protein kinase (AMPK) activation increases fatty acid oxidation in skeletal muscle by decreasing malonyl CoA concentrations. However, this may not explain the long-term effects of AMPK activation. Here we show that AMPK activation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) increases mRNA expression of PPARalpha target genes and PGC-1 in cultured muscle cells and mouse skeletal muscle, and that inhibition of PPARalpha and PGC-1 by siRNAs prevents AICAR-stimulated increase in fatty acid oxidation. These data suggest that a novel transcriptional regulatory mechanism involving PPARalpha and PGC-1 exists that is responsible for long-term stimulation of fatty acid oxidation in skeletal muscle by AICAR.
Insights
AMP-activated protein kinase (AMPK) activation stimulates long-term fatty acid oxidation in skeletal muscle. This involves a new pathway mediated by PPARalpha and PGC-1, enhancing gene expression for sustained metabolic effects.
Area of Science:
- Biochemistry
- Molecular Biology
- Exercise Physiology
Background:
- AMP-activated protein kinase (AMPK) activation is known to increase fatty acid oxidation in skeletal muscle.
- The short-term mechanism involves reduced malonyl CoA concentrations.
- Long-term effects of AMPK activation on fatty acid metabolism require further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the long-term stimulation of fatty acid oxidation by AMPK activation in skeletal muscle.
- To identify key transcriptional regulators involved in this process.
Main Methods:
- Utilized cultured muscle cells and mouse skeletal muscle models.
- Administered 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) to activate AMPK.
- Employed small interfering RNAs (siRNAs) to inhibit peroxisome proliferator-activated receptor alpha (PPARalpha) and peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1).
- Measured mRNA expression of PPARalpha target genes and PGC-1.
Main Results:
- AICAR-induced AMPK activation increased mRNA expression of PPARalpha target genes and PGC-1 in muscle cells and mouse skeletal muscle.
- Inhibition of PPARalpha and PGC-1 using siRNAs abolished the AICAR-stimulated increase in fatty acid oxidation.
- These findings indicate a crucial role for PPARalpha and PGC-1 in mediating the long-term effects of AICAR on fatty acid metabolism.
Conclusions:
- A novel transcriptional regulatory mechanism involving PPARalpha and PGC-1 mediates the long-term stimulation of fatty acid oxidation in skeletal muscle by AICAR.
- This pathway provides new insights into the metabolic adaptations to AMPK activation in muscle tissue.
- Highlights potential therapeutic targets for metabolic disorders through modulation of this pathway.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Two...
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Metabolic States of the Body: Fasting and Starvation
